Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Andrology

Free Subscription Articles published in J Urol Retrieve available abstracts of 222 articles: HTML format

Single Articles

July 2026
1. RITCH CR
   Urologic Oncology: Bladder, Penis, and Urethral Cancer and Basic Principles of Oncology.
   J Urol. 2026 Jul 31:101097JU0000000000005218. doi: 10.1097/JU.0000000000005218.
   PubMed    
   
   
   
2. MOUSA A, Chavarriaga J, Kaushal S, Burrafato Z, et al
   Primary Retroperitoneal Lymph Node Dissection in Marker-Positive Clinical Stage II Nonseminomatous Germ Cell Tumors: Erratum.
   J Urol. 2026;216:134-136.
   PubMed    
   
   
   
3. GONZALEZ-CARRANZA HR, Reyes-Vallejo LA
   Letter: Testosterone Does Not Drive Prostate Cancer: Presenting the New Framework of Androgen Adequacy Versus Inadequacy.
   J Urol. 2026;216:118-119.
   PubMed    
   
   
   June 2026
4. TYAGI P
   Letter: Testosterone Does Not Drive Prostate Cancer: Presenting the New Framework of Androgen Adequacy vs Inadequacy.
   J Urol. 2026 Jun 25:101097JU0000000000005160. doi: 10.1097/JU.0000000000005160.
   PubMed    
   
   
   
5. WYMER KM, Koo K
   Reframing the Spectrum of Benign Prostatic Hyperplasia Management: Impact and Implications of the 2026 AUA Guideline.
   J Urol. 2026 Jun 12:101097JU0000000000005162. doi: 10.1097/JU.0000000000005162.
   PubMed    
   
   
   
6. RITCH CR
   Bladder, Penis, and Urethral Cancers and Basic Principles of Oncology.
   J Urol. 2026 Jun 4:101097JU0000000000005136. doi: 10.1097/JU.0000000000005136.
   PubMed    
   
   
   
7. KAVOUSSI PK, Weiss J, Pyo J, Mehrabani-Farsi R, et al
   Semen Parameter Response to Varicocele Repair in Infertile Men With Cryptozoospermia.
   J Urol. 2026;215:729-736.
   PubMed     Abstract available
   
   
   
8. CLEMENS JQ, Naliboff BD, Bradley CS, Yang CC, et al
   Transitions From Regional to Widespread Pain in Urologic Chronic Pelvic Pain Syndrome: A Multidisciplinary Approach to the Study of Chronic Pelvic Pain II Research Network Study.
   J Urol. 2026;215:746-755.
   PubMed     Abstract available
   
   
   May 2026
9. RAMASWAMY A, Kaplan SA
   In the Emerging Era of GLP-1 Receptor Agonists There Is an Unrecognized Need to Change the Formulation of Oral Urologic Agents for Erectile Dysfunction, Benign Prostatic Hyperplasia, and Overactive Bladder.
   J Urol. 2026 May 26:101097JU0000000000005120. doi: 10.1097/JU.0000000000005120.
   PubMed    
   
   
   
10. UY M, DiBianco JM, Mansour S, Daignault-Newton S, et al
    Predictors of Medication Cessation After Benign Prostatic Hyperplasia Procedures.
    J Urol. 2026 May 17:101097JU0000000000005091. doi: 10.1097/JU.0000000000005091.
    PubMed     Abstract available
    
    
    
11. GOUELI R, Badlani GH, Welliver C, Anderson PD, et al
    Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline (2026) Part I: Presentation and Evaluation.
    J Urol. 2026 May 7:101097JU0000000000005097. doi: 10.1097/JU.0000000000005097.
    PubMed     Abstract available
    
    
    
12. GOUELI R, Badlani GH, Welliver C, Anderson PD, et al
    Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline (2026) Part II: Medical Management.
    J Urol. 2026 May 7:101097JU0000000000005098. doi: 10.1097/JU.0000000000005098.
    PubMed     Abstract available
    
    
    
13. GOUELI R, Badlani GH, Welliver C, Anderson PD, et al
    Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA Guideline (2026) Part III: Procedural/Surgical Management.
    J Urol. 2026 May 7:101097JU0000000000005099. doi: 10.1097/JU.0000000000005099.
    PubMed     Abstract available
    
    
    
14. RITCH CR
    Urologic Oncology: Bladder, Penis, and Urethral Cancer and Basic Principles of Oncology.
    J Urol. 2026 May 4:101097JU0000000000005059. doi: 10.1097/JU.0000000000005059.
    PubMed    
    
    
    April 2026
15. KLEMM J, Miernik F, Roessler N, Schulz RJ, et al
    Psychometric and Linguistic External Validation of the Urethral Stricture Symptom and Impact Measure and Its Association With Treatment Satisfaction and Decision Regret After Anterior Urethroplasty.
    J Urol. 2026 Apr 29:101097JU0000000000005072. doi: 10.1097/JU.0000000000005072.
    PubMed     Abstract available
    
    
    
16. TOUMAZOS K, Feygin Y, Gupta N, Walker J, et al
    Survivorship after Testicular Cancer in Adolescents and Young Adults- What is Causing Death and When?
    J Urol. 2026 Apr 28:101097JU0000000000005101. doi: 10.1097/JU.0000000000005101.
    PubMed     Abstract available
    
    
    
17. AL HOMSI A, Raheem OA
    Letter: Cross-Sectional Association of Time Spent Outdoors With Serum Testosterone: Results From the National Health and Nutrition Examination Survey.
    J Urol. 2026;215:472.
    PubMed    
    
    
    March 2026
18. RITCH CR
    Urologic Oncology: Bladder, Penis, and Urethral Cancer and Basic Principles of Oncology.
    J Urol. 2026 Mar 10:101097JU0000000000005010. doi: 10.1097/JU.0000000000005010.
    PubMed    
    
    
    
19. KAPLAN SA
    Benign Prostatic Hyperplasia.
    J Urol. 2026 Mar 6:101097JU0000000000005009. doi: 10.1097/JU.0000000000005009.
    PubMed    
    
    
    
20. LIN YH
    Reply: A New Framework for Testosterone Deficiency: Integrating Organ-Specific and Circadian Thresholds.
    J Urol. 2026;215:348-349.
    PubMed    
    
    
    
21. LOUGHLIN KR
    Letter: A New Framework for Testosterone Deficiency: Integrating Organ-Specific and Circadian Thresholds.
    J Urol. 2026;215:347.
    PubMed    
    
    
    February 2026
22. MURRAY DP, Dietrich PN, Sandlow JI
    Advancing Vasectomy Care: Reflections on the 2026 AUA Guideline Updates, Clinical Implications, and Research Priorities.
    J Urol. 2026 Feb 20:101097JU0000000000005008. doi: 10.1097/JU.0000000000005008.
    PubMed    
    
    
    
23. LAWEN T, Garcia RS, Smith MT, Pyo J, et al
    Low Testosterone Levels and Grade Group Progression Among Localized Prostate Cancer Patients on Active Surveillance: A Retrospective Cohort Study.
    J Urol. 2026 Feb 9:101097JU0000000000004986. doi: 10.1097/JU.0000000000004986.
    PubMed     Abstract available
    
    
    
24. POLLOCK NL, Chang J, Onishi E, Chatton A, et al
    Effectiveness and complications of vasectomy with fascial interposition without mucosal cautery: a retrospective cohort study.
    J Urol. 2026 Feb 9:101097JU0000000000004984. doi: 10.1097/JU.0000000000004984.
    PubMed     Abstract available
    
    
    
25. RITCH CR
    Urologic Oncology: Bladder, Penis, and Urethral Cancer and Basic Principles of Oncology.
    J Urol. 2026 Feb 3:101097JU0000000000004946. doi: 10.1097/JU.0000000000004946.
    PubMed    
    
    
    January 2026
26. SCHLEGEL PN, Vij SC, Filson C, Penzo-Mendez A, et al
    Vasectomy and the Risk of Prostate Cancer.
    J Urol. 2026 Jan 20:101097JU0000000000004937. doi: 10.1097/JU.0000000000004937.
    PubMed    
    
    
    
27. MORGENTALER A, Traish AM
    TESTOSTERONE DOES NOT DRIVE PROSTATE CANCER: PRESENTING THE NEW FRAMEWORK OF ANDROGEN ADEQUACY VERSUS INADEQUACY.
    J Urol. 2026 Jan 13:101097JU0000000000004936. doi: 10.1097/JU.0000000000004936.
    PubMed     Abstract available
    
    
    
28. SHIRAISHI K, Tokitaka S, Ban Y, Oka S, et al
    Long-Term Outcomes of Varicocelectomy in Children and Adolescents: Impact of Timing on Testicular Growth and Spermatogenesis.
    J Urol. 2026 Jan 13:101097JU0000000000004934. doi: 10.1097/JU.0000000000004934.
    PubMed     Abstract available
    
    
    December 2025
29. RITCH CR
    Urologic Oncology: Bladder, Penis, and Urethral Cancer, and Basic Principles of Oncology.
    J Urol. 2025 Dec 19:101097JU0000000000004884. doi: 10.1097/JU.0000000000004884.
    PubMed    
    
    
    
30. RITCH CR
    Urologic Oncology: Bladder, Penis, and Urethral Cancer, and Basic Principles of Oncology.
    J Urol. 2025 Dec 16:101097JU0000000000004885. doi: 10.1097/JU.0000000000004885.
    PubMed    
    
    
    
31. KAPLAN SA, Parekattil SJ, Wu NZ, Mazzarella B, et al
    12-Month Outcomes from a Randomized, Sham Controlled Trial Evaluating a Novel Prostatic Urethral Stent for the Treatment of Benign Prostatic Hyperplasia.
    J Urol. 2025 Dec 15:101097JU0000000000004896. doi: 10.1097/JU.0000000000004896.
    PubMed     Abstract available
    
    
    
32. SCHLEGEL PN, Clark JY, Coward RM, Hirshberg SJ, et al
    Fertility Restoration After Vasectomy: AUA Guideline Part II.
    J Urol. 2025 Dec 9:101097JU0000000000004862. doi: 10.1097/JU.0000000000004862.
    PubMed     Abstract available
    
    
    
33. SCHLEGEL PN, Clark JY, Coward RM, Hirshberg SJ, et al
    Vasectomy: AUA Guideline Part I.
    J Urol. 2025 Dec 9:101097JU0000000000004861. doi: 10.1097/JU.0000000000004861.
    PubMed     Abstract available
    
    
    
34. BHAMBHVANI HP, Kuchakulla M, Poppas P, Greenberg DR, et al
    Reply: Cross-Sectional Association of Time Spent Outdoors With Serum Testosterone: Results From National Health and Nutrition Examination Survey.
    J Urol. 2025 Dec 9:101097JU0000000000004868. doi: 10.1097/JU.0000000000004868.
    PubMed    
    
    
    
35. MCKIE KA, Moturu A, Graham DA, Coleman M, et al
    Antibiotic Prophylaxis Use and Outcomes in Children Undergoing Laparoscopic Orchiopexy.
    J Urol. 2025;214:622-630.
    PubMed     Abstract available
    
    
    November 2025
36. LIN YH, Chen JY, Chen CL
    Letter: Cross-Sectional Association of Time Spent Outdoors With Serum Testosterone: Results From the National Health and Nutrition Examination Survey.
    J Urol. 2025 Nov 20:101097JU0000000000004798. doi: 10.1097/JU.0000000000004798.
    PubMed    
    
    
    
37. BHAMBHVANI HP, Kuchakulla M, Poppas PJ, Greenberg DR, et al
    Reply: Cross-Sectional Association of Time Spent Outdoors With Serum Testosterone: Results From the National Health and Nutrition Examination Survey.
    J Urol. 2025 Nov 20:101097JU0000000000004810. doi: 10.1097/JU.0000000000004810.
    PubMed    
    
    
    
38. MOUSA A, Chavarriaga J, Kaushal S, Burrafato Z, et al
    Primary Retroperitoneal Lymph Node Dissection in Marker Positive Clinical Stage II Non-Seminomatous Germ Cell Tumours.
    J Urol. 2025 Nov 10:101097JU0000000000004847. doi: 10.1097/JU.0000000000004847.
    PubMed     Abstract available
    
    
    October 2025
39. RITCH CR
    Urologic Oncology: Bladder, Penis, and Urethral Cancer and Basic Principles of Oncology.
    J Urol. 2025 Oct 29:101097JU0000000000004809. doi: 10.1097/JU.0000000000004809.
    PubMed    
    
    
    September 2025
40. DAVIS MF, Nikolavsky D, Cavalcanti AG, Flynn BJ, et al
    Multicenter Analysis of Long-Term Outcomes of Artificial Urinary Sphincter Surgery Following Urethroplasty.
    J Urol. 2025 Sep 29:101097JU0000000000004794. doi: 10.1097/JU.0000000000004794.
    PubMed     Abstract available
    
    
    
41. KAPLAN SA
    Benign Prostatic Hyperplasia.
    J Urol. 2025 Sep 29:101097JU0000000000004775. doi: 10.1097/JU.0000000000004775.
    PubMed    
    
    
    
42. BHAMBHVANI HP, Kuchakulla M, Poppas P, Greenberg DR, et al
    Cross-Sectional Association of Time Spent Outdoors with Serum Testosterone: Results from NHANES.
    J Urol. 2025 Sep 19:101097JU0000000000004789. doi: 10.1097/JU.0000000000004789.
    PubMed     Abstract available
    
    
    
43. RITCH CR
    Urologic Oncology: Bladder, Penis, and Urethral Cancer and Basic Principles of Oncology.
    J Urol. 2025 Sep 11:101097JU0000000000004754. doi: 10.1097/JU.0000000000004754.
    PubMed    
    
    
    
44. RITCH CR
    Urologic Oncology: Bladder, Penis, and Urethral Cancer, and Basic Principles of Oncology.
    J Urol. 2025 Sep 2:101097JU0000000000004710. doi: 10.1097/JU.0000000000004710.
    PubMed    
    
    
    
45. HU B, Alsyouf M, Farkouh A, Cary C, et al
    Accuracy of 18F-Fluorodeoxyglucose Positron Emission Tomography in Early Metastatic Testicular Seminoma: Analysis From the SEMS Trial.
    J Urol. 2025;214:272-279.
    PubMed     Abstract available
    
    
    August 2025
46. VAVILOV S, Nolan E, Pockney P, Smith GH, et al
    Long-term risk of reoperation following hypospadias surgery in childhood: a data-linkage study.
    J Urol. 2025 Aug 12:101097JU0000000000004715. doi: 10.1097/JU.0000000000004715.
    PubMed     Abstract available
    
    
    
47. LAI HH, Pontari MA, Argoff CE, Bresler L, et al
    Male Chronic Pelvic Pain: AUA Guideline: Part I Evaluation and Management Approach.
    J Urol. 2025;214:116-126.
    PubMed     Abstract available
    
    
    
48. LAI HH, Pontari MA, Argoff CE, Bresler L, et al
    Male Chronic Pelvic Pain: AUA Guideline: Part II Treatment of Chronic Prostatitis/Chronic Pelvic Pain Syndrome.
    J Urol. 2025;214:127-137.
    PubMed     Abstract available
    
    
    July 2025
49. LIN YH, Chen JY, Wu CT
    A New Framework for Testosterone Deficiency: Integrating Organ-Specific and Circadian Thresholds.
    J Urol. 2025 Jul 24:101097JU0000000000004692. doi: 10.1097/JU.0000000000004692.
    PubMed    
    
    
    
50. MATULEWICZ RS, Assel M, Vickers AJ, Jayalath VH, et al
    Performance characteristics of an analytic model predicting retroperitoneal lymph node dissection pathology following first-line chemotherapy for patients with metastatic non-seminomatous germ cell tumors.
    J Urol. 2025 Jul 7:101097JU0000000000004668. doi: 10.1097/JU.0000000000004668.
    PubMed    
    
    
    
51. LEWER O, Felice MD, Copelan O, Janakiraman S, et al
    Prostate Size and Its Effect on Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia Improvement After Convective Water Vapor Thermal Therapy.
    J Urol. 2025;214:48-57.
    PubMed     Abstract available
    
    
    
52. KAPLAN SA
    Benign Prostatic Hyperplasia.
    J Urol. 2025 Jul 1:101097JU0000000000004640. doi: 10.1097/JU.0000000000004640.
    PubMed    
    
    
    June 2025
53. ZENG J, McFadden J, Thakker P, Tachibana I, et al
    Retroperitoneal Nodal Distribution for Metastatic Seminoma: Is Modified Template Appropriate? A Retrospective Study.
    J Urol. 2025;213:753-765.
    PubMed     Abstract available
    
    
    May 2025
54. DIETRICH P, Werner Z
    Editorial Comment: A Prospective Randomized Study on Low-Energy Extracorporeal Shockwave Therapy (LI-SWT) for Erectile Dysfunction After Radical Prostatectomy.
    J Urol. 2025 May 23:101097JU0000000000004609. doi: 10.1097/JU.0000000000004609.
    PubMed    
    
    
    
55. DMOCHOWSKI R
    Editorial Comment: A Prospective Randomized Study on Low-Energy Extracorporeal Shockwave Therapy (LI-SWT) for Erectile Dysfunction After Radical Prostatectomy.
    J Urol. 2025 May 23:101097JU0000000000004607. doi: 10.1097/JU.0000000000004607.
    PubMed    
    
    
    
56. JEFFERY J, Punjani N
    Editorial Comment on "A Prospective Randomized Study on Low-Energy Extracorporeal Shockwave Therapy (LI-SWT) for Erectile Dysfunction After Radical Prostatectomy".
    J Urol. 2025 May 23:101097JU0000000000004608. doi: 10.1097/JU.0000000000004608.
    PubMed    
    
    
    April 2025
57. KAPLAN SA
    Benign Prostatic Hyperplasia.
    J Urol. 2025 Apr 29:101097JU0000000000004572. doi: 10.1097/JU.0000000000004572.
    PubMed    
    
    
    
58. COPLEN DE
    Editorial Comment: Re: Utility of Preoperative Antimicrobial Prophylaxis in Hypospadias Repair: Results from NSQIP-Pediatric.
    J Urol. 2025 Apr 28:101097JU0000000000004575. doi: 10.1097/JU.0000000000004575.
    PubMed    
    
    
    
59. DOERSCH KM, Diamond DA
    Utility of Preoperative Antimicrobial Prophylaxis in Hypospadias Repair: Results From NSQIP-Pediatrics.
    J Urol. 2025 Apr 28:101097JU0000000000004574. doi: 10.1097/JU.0000000000004574.
    PubMed    
    
    
    
60. PEDERSEN TB, Secher C, Moumneh A, Hvid N, et al
    A Prospective Randomized Study on Low-Energy Extracorporeal Shockwave Therapy for Erectile Dysfunction After Radical Prostatectomy.
    J Urol. 2025 Apr 28:101097JU0000000000004576. doi: 10.1097/JU.0000000000004576.
    PubMed     Abstract available
    
    
    
61. LAI HH, Pontari MA, Argoff CE, Bresler L, et al
    Male Chronic Pelvic Pain: AUA Guideline: Part III Treatment of Chronic Scrotal Content Pain.
    J Urol. 2025 Apr 17:101097JU0000000000004566. doi: 10.1097/JU.0000000000004566.
    PubMed     Abstract available
    
    
    
62. CHANG SS
    Urologic Oncology: Bladder, Penis, and Urethral Cancer and Basic Principles of Oncology.
    J Urol. 2025 Apr 8:101097JU0000000000004543. doi: 10.1097/JU.0000000000004543.
    PubMed    
    
    
    
63. BASIN MF, Gopalakrishnan M, Ackerman N, Mason MD, et al
    Utility of Preoperative Antimicrobial Prophylaxis in Hypospadias Repair: Results From NSQIP-Pediatrics.
    J Urol. 2025 Apr 3:101097JU0000000000004558. doi: 10.1097/JU.0000000000004558.
    PubMed     Abstract available
    
    
    March 2025
64. CHANG SS
    Urologic Oncology: Bladder, Penis, and Urethral Cancer, and Basic Principles of Oncology.
    J Urol. 2025 Mar 27:101097JU0000000000004520. doi: 10.1097/JU.0000000000004520.
    PubMed    
    
    
    
65. NI X, Sui J, Wang B, Wang H, et al
    Lower Testosterone level and metastases-free survival in nmCRPC patients treated with novel antiandrogens: A post-hoc analysis of SPARTAN and ARAMIS.
    J Urol. 2025 Mar 25:101097JU0000000000004545. doi: 10.1097/JU.0000000000004545.
    PubMed     Abstract available
    
    
    February 2025
66. CHANG SS
    Urologic Oncology: Bladder, Penis, and Urethral Cancer and Basic Principles of Oncology.
    J Urol. 2025 Feb 26:101097JU0000000000004479. doi: 10.1097/JU.0000000000004479.
    PubMed    
    
    
    
67. CHANG SS
    Urologic Oncology: Bladder, Penis, and Urethral Cancer and Basic Principles of Oncology.
    J Urol. 2025 Feb 21:101097JU0000000000004389. doi: 10.1097/JU.0000000000004389.
    PubMed    
    
    
    
68. KAPLAN SA
    Benign Prostatic Hyperplasia.
    J Urol. 2025 Feb 17:101097JU0000000000004471. doi: 10.1097/JU.0000000000004471.
    PubMed    
    
    
    
69. PANDIT K, Morgan K, Riviere P, Dabbas M, et al
    Reply: Incidence of Erectile Dysfunction and Testosterone Deficiency in Testicular Cancer Survivors.
    J Urol. 2025 Feb 12:101097JU0000000000004461. doi: 10.1097/JU.0000000000004461.
    PubMed    
    
    
    
70. HINOJOSA-GONZALEZ DE
    Letter: Comparative Analysis of Holmium Laser Enucleation of the Prostate and Robotic-Assisted Simple Prostatectomy in Benign Prostatic Hyperplasia Management: A Systematic Review and Meta-Analysis.
    J Urol. 2025 Feb 10:101097JU0000000000004454. doi: 10.1097/JU.0000000000004454.
    PubMed    
    
    
    
71. WANG W, Gao C, Fu K
    Letter: Incidence of Erectile Dysfunction and Testosterone Deficiency in Testicular Cancer Survivors.
    J Urol. 2025 Feb 3:101097JU0000000000004440. doi: 10.1097/JU.0000000000004440.
    PubMed    
    
    
    
72. BENZOUAK T, Addar A, Prudencio-Brunello MA, Saed Aldien A, et al
    Comparative Analysis of Holmium Laser Enucleation of the Prostate and Robotic-Assisted Simple Prostatectomy in Benign Prostatic Hyperplasia Management: A Systematic Review and Meta-Analysis.
    J Urol. 2025;213:150-161.
    PubMed     Abstract available
    
    
    
73. CHANG SS
    Urologic Oncology: Bladder, Penis, and Urethral Cancer, and Basic Principles of Oncology.
    J Urol. 2025;213:264-265.
    PubMed    
    
    
    January 2025
74. CHANG SS
    Urologic Oncology: Bladder, Penis, and Urethral Cancer and Basic Principles of Oncology.
    J Urol. 2025 Jan 23:101097JU0000000000004418. doi: 10.1097/JU.0000000000004418.
    PubMed    
    
    
    
75. HENGEL R, Vanni A, Erickson B, Elliott S, et al
    Multi-Institutional Analysis of Surgery for Lichen Sclerosus Induced Penile Urethral Stricture: Establishing Single-Stage Urethroplasty as a Primary Treatment Option.
    J Urol. 2025 Jan 21:101097JU0000000000004434. doi: 10.1097/JU.0000000000004434.
    PubMed     Abstract available
    
    
    
76. ABBASI B, Hacker E, Ghaffar U, Hakam N, et al
    Higher Morbidity and Mortality in Females With Fournier Gangrene Compared With Males: Insights From National Inpatient Sample Data.
    J Urol. 2025;213:99-109.
    PubMed     Abstract available
    
    
    December 2024
77. HA A, Zhang CA, Li S, Langroudi AP, et al
    A Contemporary Estimate of Vasectomy Failure in the United States: Analysis of US Claims Data.
    J Urol. 2024 Dec 31:101097JU0000000000004405. doi: 10.1097/JU.0000000000004405.
    PubMed     Abstract available
    
    
    
78. CHANG SS
    Urologic Oncology: Bladder, Penis, and Urethral Cancer and Basic Principles of Oncology.
    J Urol. 2024 Dec 11:101097JU0000000000004349. doi: 10.1097/JU.0000000000004349.
    PubMed    
    
    
    
79. ERICKSON BA, Tuong MN, Zorn AN, Schlaepfer CH, et al
    Development and Validation of the Length, Segment, and Etiology (LSE) Anterior Urethral Stricture Disease Staging System Using Longitudinal Urethroplasty Outcomes Data from the Trauma and Urologic Reconstruction Network of Surgeons.
    J Urol. 2024 Dec 9:101097JU0000000000004369. doi: 10.1097/JU.0000000000004369.
    PubMed     Abstract available
    
    
    
80. KAPLAN SA
    Benign Prostatic Hyperplasia.
    J Urol. 2024 Dec 9:101097JU0000000000004345. doi: 10.1097/JU.0000000000004345.
    PubMed    
    
    
    
81. LEUNBACH TL, Berglund A, Ernst A, Hvistendahl GM, et al
    Prevalence, Incidence, and Age at Diagnosis of Boys With Hypospadias: A Nationwide Population-Based Epidemiological Study.
    J Urol. 2024 Dec 3:101097JU0000000000004319. doi: 10.1097/JU.0000000000004319.
    PubMed     Abstract available
    
    
    
82. GREENBERG DR, Gago LC, Kumar SKSR, Panken EJ, et al
    Epididymal Cyst Lesions Are Not Associated With Impaired Semen Parameters Among Men Presenting for Fertility Evaluation.
    J Urol. 2024;212:891-898.
    PubMed     Abstract available
    
    
    
83. BRANNIGAN RE, Hermanson L, Kaczmarek J, Kim SK, et al
    Updates to Male Infertility: AUA/ASRM Guideline (2024).
    J Urol. 2024;212:789-799.
    PubMed     Abstract available
    
    
    
84. KAPLAN SA
    Benign Prostatic Hyperplasia.
    J Urol. 2024;212:924-926.
    PubMed    
    
    
    November 2024
85. CHANG SS
    Urologic Oncology: Bladder, Penis, and Urethral Cancer and Basic Principles of Oncology.
    J Urol. 2024 Nov 20:101097JU0000000000004320. doi: 10.1097/JU.0000000000004320.
    PubMed    
    
    
    
86. NESTLER T, Heidenreich A
    Letter: Eleven-Year Experience With Midline Extraperitoneal Retroperitoneal Lymph Node Dissection for Germ Cell Tumors.
    J Urol. 2024 Nov 5:101097JU0000000000004304. doi: 10.1097/JU.0000000000004304.
    PubMed    
    
    
    
87. CHANG SS
    Urological Oncology: Bladder, Penis, and Urethra Cancer, and Basic Principles of Oncology.
    J Urol. 2024;212:779-780.
    PubMed    
    
    
    October 2024
88. CHANG SS
    Urologic Oncology: Bladder, Penis, and Urethral Cancers and Basic Principles of Oncology.
    J Urol. 2024 Oct 24:101097JU0000000000004288. doi: 10.1097/JU.0000000000004288.
    PubMed    
    
    
    
89. STASKIN D, Owens-Grillo J, Thomas E, Rovner E, et al
    Reply: Letter: Efficacy and Safety of Vibegron for Persistent Symptoms of Overactive Bladder in Men Being Pharmacologically Treated for Benign Prostatic Hyperplasia: Results From the Phase 3 COURAGE Trial.
    J Urol. 2024 Oct 23:101097JU0000000000004291. doi: 10.1097/JU.0000000000004291.
    PubMed    
    
    
    
90. CHANG SS
    Urologic Oncology: Bladder, Penis, and Urethral Cancer, and Basic Principles of Oncology.
    J Urol. 2024 Oct 8:101097JU0000000000004240. doi: 10.1097/JU.0000000000004240.
    PubMed    
    
    
    
91. NIEDERBERGER C
    Male Infertility.
    J Urol. 2024;212:633-635.
    PubMed    
    
    
    
92. CHANG SS
    Urologic Oncology: Bladder, Penis, and Urethral Cancer, and Basic Principles of Oncology.
    J Urol. 2024;212:639-640.
    PubMed    
    
    
    September 2024
93. FLORES JM, Vertosick EA, Salter CA, Benfante N, et al
    Testosterone Therapy in Men After Radical Prostatectomy for Organ-Confined, Low-Intermediate Prostate Cancer.
    J Urol. 2024 Sep 30:101097JU0000000000004267. doi: 10.1097/JU.0000000000004267.
    PubMed     Abstract available
    
    
    
94. PANDIT K, Riviere P, Morgan K, Nelson T, et al
    Incidence of Erectile Dysfunction and Testosterone Deficiency in Testicular Cancer Survivors.
    J Urol. 2024 Sep 30:101097JU0000000000004259. doi: 10.1097/JU.0000000000004259.
    PubMed     Abstract available
    
    
    
95. DIECKMANN KP, Belge G
    Letter: miR-371a-3p Predicting Viable Tumor in Patients Undergoing Retroperitoneal Lymph Node Dissection for Metastatic Testicular Cancer: The SWENOTECA-MIR Study.
    J Urol. 2024 Sep 17:101097JU0000000000004241. doi: 10.1097/JU.0000000000004241.
    PubMed    
    
    
    
96. ALSYOUF M, Ghoreifi A, Ashrafi A, Ladi-Seyedian SS, et al
    11-Year Experience With Midline Extraperitoneal Retroperitoneal Lymph Node Dissection for Germ Cell Tumors.
    J Urol. 2024 Sep 13:101097JU0000000000004246. doi: 10.1097/JU.0000000000004246.
    PubMed     Abstract available
    
    
    
97. TROST L, Mulhall J, Hellstrom W
    Creation of a Novel Classification System (PTNM) for Peyronie's Disease and Penile Curvature Using Evidence-Based Criteria.
    J Urol. 2024;212:470-482.
    PubMed     Abstract available
    
    
    August 2024
98. CHANG SS
    Urologic Oncology: Bladder, Penis, and Urethral Cancer, and Basic Principles of Oncology.
    J Urol. 2024 Aug 22:101097JU0000000000004206. doi: 10.1097/JU.0000000000004206.
    PubMed    
    
    
    
99. YU T, Yang Y, Shan D, Li J, et al
    Letter: Efficacy and Safety of Vibegron for Persistent Symptoms of Overactive Bladder in Men Being Pharmacologically Treated for Benign Prostatic Hyperplasia: Results From the Phase 3 Randomized Controlled COURAGE Trial.
    J Urol. 2024 Aug 22:101097JU0000000000004200. doi: 10.1097/JU.0000000000004200.
    PubMed    
    
    
    
100. KAPLAN SA
     Benign Prostatic Hyperplasia.
     J Urol. 2024 Aug 20:101097JU0000000000004211. doi: 10.1097/JU.0000000000004211.
     PubMed    
     
     
     
101. GU C, Belarmino A, Kenfield SA, Nolte D, et al
     Post-Vasectomy Semen Analysis Compliance With Utilization of a Mail-In Semen Analysis Kit.
     J Urol. 2024 Aug 2:101097JU0000000000004185. doi: 10.1097/JU.0000000000004185.
     PubMed     Abstract available
     
     
     
102. NIEDERBERGER C
     Male Infertility.
     J Urol. 2024;212:386-388.
     PubMed    
     
     
     
103. PATEL HV, Li KD, Rourke K, Smith TG 3rd, et al
     The Impact of Social Deprivation on Anterior Urethral Stricture Recurrence After Urethroplasty - A Trauma and Urologic Reconstructive Network of Surgeons (TURNS) Analysis.
     J Urol. 2024 Aug 1:101097JU0000000000004188. doi: 10.1097/JU.0000000000004188.
     PubMed     Abstract available
     
     
     
104. KAPLAN SA
     Benign Prostatic Hyperplasia.
     J Urol. 2024;212:381-384.
     PubMed    
     
     
     July 2024
105. ALSYOUF M, Daneshmand S
     Moving the Needle in Early Stage Testicular Germ Cell Tumor Management: The MAGESTIC Trial.
     J Urol. 2024 Jul 31:101097JU0000000000004182. doi: 10.1097/JU.0000000000004182.
     PubMed    
     
     
     
106. THOR A, Myklebust MP, Bergdahl AG, Lundgren PO, et al
     miR-371a-3p Predicting Viable Tumor in Patients Undergoing RPLND for Metastatic Testicular Cancer: The SWENOTECA-MIR Study.
     J Urol. 2024 Jul 25:101097JU0000000000004164. doi: 10.1097/JU.0000000000004164.
     PubMed     Abstract available
     
     
     
107. CHANG SS
     Urological Oncology: Bladder, Penis and Urethra Cancer, and Basic Principles of Oncology.
     J Urol. 2024 Jul 25:101097JU0000000000004153. doi: 10.1097/JU.0000000000004153.
     PubMed    
     
     
     
108. BATUR AF, Altintas E, Gul M
     Letter: Efficacy and Safety of Vibegron for Persistent Symptoms of Overactive Bladder in Men Being Pharmacologically Treated for Benign Prostatic Hyperplasia: Results From the Phase 3 Randomized Controlled COURAGE Trial.
     J Urol. 2024 Jul 25:101097JU0000000000004156. doi: 10.1097/JU.0000000000004156.
     PubMed    
     
     
     
109. CHANG SS
     Urological Oncology: Bladder, Penis, and Urethra Cancer, and Basic Principles of Oncology.
     J Urol. 2024 Jul 25:101097JU0000000000004120. doi: 10.1097/JU.0000000000004120.
     PubMed    
     
     
     
110. LAZAROVICH A, Dahmen AS, Modi PK, Agarawal PK, et al
     Urologic Oncology: Bladder, Penis, and Urethral Cancer, and Basic Principles of Oncology.
     J Urol. 2024;212:236-237.
     PubMed    
     
     
     
111. NIEDERBERGER C
     Male Infertility.
     J Urol. 2024;212:247-248.
     PubMed    
     
     
     
112. KAPLAN SA
     BPH.
     J Urol. 2024;212:241-243.
     PubMed    
     
     
     
113. HAYON S, Kumar SKS, Greenberg D, Mi X, et al
     Distribution and Positive Predictive Value of Follicle Stimulating Hormone Among Nonazoospermic Men.
     J Urol. 2024;212:145-152.
     PubMed     Abstract available
     
     
     
114. 
     Gabapentin for Postoperative Pain Control and Opioid Reduction in Scrotal Surgery: A Randomized Controlled Clinical Trial: Erratum.
     J Urol. 2024;212:249.
     PubMed    
     
     
     June 2024
115. CHANG SS
     Urologic Oncology: Bladder, Penis, and Urethral Cancer, and Basic Principles of Oncology.
     J Urol. 2024 Jun 17:101097JU0000000000004092. doi: 10.1097/JU.0000000000004092.
     PubMed    
     
     
     
116. KAPLAN SA
     Benign Prostatic Hyperplasia.
     J Urol. 2024 Jun 11:101097JU0000000000004083. doi: 10.1097/JU.0000000000004083.
     PubMed    
     
     
     
117. NIEDERBERGER C
     Male Infertility.
     J Urol. 2024;211:809-811.
     PubMed    
     
     
     
118. NIEDERBERGER C
     Male Infertility.
     J Urol. 2024;211:814-816.
     PubMed    
     
     
     
119. 
     Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: AUA GUIDELINE PART I-Initial Work-up and Medical Management: Erratum.
     J Urol. 2024;211:820.
     PubMed    
     
     
     
120. KAPLAN SA
     Benign Prostatic Hyperplasia.
     J Urol. 2024;211:811-813.
     PubMed    
     
     
     May 2024
121. KAPLAN SA
     Benign Prostatic Hyperplasia.
     J Urol. 2024 May 24:101097JU0000000000003951. doi: 10.1097/JU.0000000000003951.
     PubMed    
     
     
     
122. KAPLAN SA
     Benign Prostatic Hyperplasia.
     J Urol. 2024 May 17:101097JU0000000000004026. doi: 10.1097/JU.0000000000004026.
     PubMed    
     
     
     
123. CHANG SS
     Urologic Oncology: Bladder, Penis, and Urethral Cancer, and Basic Principles of Oncology.
     J Urol. 2024 May 17:101097JU0000000000004018. doi: 10.1097/JU.0000000000004018.
     PubMed    
     
     
     
124. STASKIN D, Owens-Grillo J, Thomas E, Rovner E, et al
     Efficacy and Safety of Vibegron for Persistent Symptoms of Overactive Bladder in Men Being Pharmacologically Treated for Benign Prostatic Hyperplasia: Results From the Phase 3 Randomized Controlled COURAGE Trial.
     J Urol. 2024 May 6:101097JU0000000000003999. doi: 10.1097/JU.0000000000003999.
     PubMed     Abstract available
     
     
     
125. MOULI S, Salem R, McClure TD
     Prostate Artery Embolization for Benign Prostatic Hyperplasia.
     J Urol. 2024 May 4:101097JU0000000000003976. doi: 10.1097/JU.0000000000003976.
     PubMed    
     
     
     
126. TROST L
     Reply: Comparison of Collagenase Clostridium histolyticum to Surgery for the Management of Peyronie's Disease: A Randomized Trial.
     J Urol. 2024;211:710-712.
     PubMed    
     
     
     
127. DESOUKY E, Levine LA
     Letter: Comparison of Collagenase Clostridium histolyticum to Surgery for the Management of Peyronie's Disease: A Randomized Trial.
     J Urol. 2024;211:708-709.
     PubMed    
     
     
     
128. NIEDERBERGER C
     Male Infertility.
     J Urol. 2024;211:722-723.
     PubMed    
     
     
     
129. CHANG SS
     Urologic Oncology: Bladder, Penis, and Urethral Cancer, and Basic Principles of Oncology.
     J Urol. 2024;211:720-721.
     PubMed    
     
     
     
130. CHANG SS
     Urologic Oncology: Bladder, Penis, and Urethral Cancer, and Basic Principles of Oncology.
     J Urol. 2024;211:720-721.
     PubMed    
     
     
     April 2024
131. CHANG SS
     Urologic Oncology: Bladder, Penis, and Urethral Cancer, and Basic Principles of Oncology.
     J Urol. 2024 Apr 22:101097JU0000000000003900. doi: 10.1097/JU.0000000000003900.
     PubMed    
     
     
     
132. PINKHASOV AM, Viers BR
     Letter: Multi-Institutional Outcomes of Dorsal Onlay Buccal Mucosal Graft Urethroplasty in Patients With Postprostatectomy, Postradiation Anastomotic Stenosis.
     J Urol. 2024 Apr 10:101097JU0000000000003939. doi: 10.1097/JU.0000000000003939.
     PubMed    
     
     
     
133. TROST L
     Update to the Testosterone Guideline.
     J Urol. 2024;211:608-610.
     PubMed    
     
     
     
134. NIEDERBERGER C
     Male Infertility.
     J Urol. 2024;211:631-633.
     PubMed    
     
     
     
135. KAPLAN SA
     Benign Prostatic Hyperplasia.
     J Urol. 2024;211:630-631.
     PubMed    
     
     
     
136. CHANG SS
     Urological Oncology: Bladder, Penis and Urethra Cancer, and Basic Principles of Oncology.
     J Urol. 2024;211:638-639.
     PubMed    
     
     
     March 2024
137. KAPLAN SA
     Benign Prostatic Hyperplasia.
     J Urol. 2024 Mar 20:101097JU0000000000003872. doi: 10.1097/JU.0000000000003872.
     PubMed    
     
     
     
138. CHANG SS
     Urologic Oncology: Bladder, Penis, and Urethral Cancer, and Basic Principles of Oncology.
     J Urol. 2024 Mar 15:101097JU0000000000003875. doi: 10.1097/JU.0000000000003875.
     PubMed    
     
     
     
139. BARKER ES, Chiu K, Brown VL, Morsy H, et al
     Urologic Chronic Pelvic Pain Syndrome Flares: A Comprehensive, Systematic Review and Meta-Analysis of the Peer-Reviewed Flare Literature.
     J Urol. 2024;211:341-353.
     PubMed     Abstract available
     
     
     
140. NIEDERBERGER C
     Male Infertility.
     J Urol. 2024;211:489-490.
     PubMed    
     
     
     
141. NESTLER T, Paffenholz P, Pfister D, Schoch J, et al
     Adjunctive Surgery Is Often Without Oncological Benefit at Time of Postchemotherapy Retroperitoneal Lymph Node Dissection.
     J Urol. 2024;211:426-435.
     PubMed     Abstract available
     
     
     
142. CHANG SS
     Urological Oncology: Bladder, Penis and Urethra Cancer, and Basic Principles of Oncology.
     J Urol. 2024;211:500-501.
     PubMed    
     
     
     
143. KAPLAN SA
     Benign Prostatic Hyperplasia.
     J Urol. 2024;211:485-487.
     PubMed    
     
     
     February 2024
144. PUNJANI N, Marinaro JA, Kang C, Gal J, et al
     Gabapentin for Post-operative Pain Control and Opioid Reduction in Scrotal Surgery: A Randomized Controlled Clinical Trial.
     J Urol. 2024 Feb 21:101097JU0000000000003884. doi: 10.1097/JU.0000000000003884.
     PubMed     Abstract available
     
     
     
145. NG L, Kocur OM, Xie P, Cheung S, et al
     Timing of Testicular Biopsy in Relation to Oocyte Retrieval and the Outcomes of Intracytoplasmic Sperm Injection.
     J Urol. 2024 Feb 20:101097JU0000000000003894. doi: 10.1097/JU.0000000000003894.
     PubMed     Abstract available
     
     
     
146. CHANG KC, Hung SF
     Letter: Serum Testosterone and Dihydrotestosterone and Incidence and Progression of Lower Urinary Tract Symptoms: Results From the REDUCE Study.
     J Urol. 2024 Feb 13:101097JU0000000000003861. doi: 10.1097/JU.0000000000003861.
     PubMed    
     
     
     
147. DEEBEL N, Ramasamy R
     Letter: Age, Sperm Retrieval, and Testicular Histology in Klinefelter Syndrome.
     J Urol. 2024 Feb 7:101097JU0000000000003867. doi: 10.1097/JU.0000000000003867.
     PubMed    
     
     
     
148. KAPLAN-MARANS E, Khurgin J
     Letter: Age, Sperm Retrieval, and Testicular Histology in Klinefelter Syndrome.
     J Urol. 2024 Feb 7:101097JU0000000000003868. doi: 10.1097/JU.0000000000003868.
     PubMed    
     
     
     
149. GREENBERG DR, Panken EJ, Amarasekera C
     Platelet-Rich Plasma for Urologic Conditions: An Early Call for Composition Reporting.
     J Urol. 2024;211:313-316.
     PubMed    
     
     
     
150. CHANG SS
     Urological Oncology: Bladder, Penis and Urethra Cancer, and Basic Principles of Oncology.
     J Urol. 2024;211:334-335.
     PubMed    
     
     
     January 2024
151. STERLING J, Simhan J, Flynn BJ, Rusilko P, et al
     Multi-Institutional Outcomes of Dorsal Onlay Buccal Mucosal Graft Urethroplasty in Patients With Postprostatectomy, Postradiation Anastomotic Stenosis.
     J Urol. 2024 Jan 26:101097JU0000000000003848. doi: 10.1097/JU.0000000000003848.
     PubMed     Abstract available
     
     
     
152. CHANG SS
     Urological Oncology: Bladder, Penis and Urethra Cancer, and Basic Principles of Oncology.
     J Urol. 2024 Jan 19:101097JU0000000000003839. doi: 10.1097/JU.0000000000003839.
     PubMed    
     
     
     
153. KAPLAN SA
     Benign Prostatic Hyperplasia.
     J Urol. 2024 Jan 15:101097JU0000000000003807. doi: 10.1097/JU.0000000000003807.
     PubMed    
     
     
     
154. O'CONNELL KA, Thomas JL, Murad F, Zhou G, et al
     Total Margin Control Is Superior to Traditional Margin Assessment for Treatment of Low-Stage Penile Squamous Cell Carcinoma.
     J Urol. 2024;211:90-100.
     PubMed     Abstract available
     
     
     
155. MATULEWICZ RS, Benfante N, Funt SA, Feldman DR, et al
     Primary Retroperitoneal Lymph Node Dissection for Seminoma Metastatic to the Retroperitoneum.
     J Urol. 2024;211:80-89.
     PubMed     Abstract available
     
     
     December 2023
156. CALVO CI, Fender K, Hoy N, Rourke K, et al
     Affirming Long-Term Outcomes after Contemporary Urethroplasty: The Adverse Impact of Increasing Stricture Length, Lichen Sclerosus, Radiation and Infectious Strictures.
     J Urol. 2023 Dec 18:101097JU0000000000003826. doi: 10.1097/JU.0000000000003826.
     PubMed     Abstract available
     
     
     
157. CHANG SS
     Urological Oncology: Bladder, Penis and Urethra Cancer, and Basic Principles of Oncology.
     J Urol. 2023 Dec 14:101097JU0000000000003806. doi: 10.1097/JU.0000000000003806.
     PubMed    
     
     
     
158. KAPLAN SA
     Benign Prostatic Hyperplasia.
     J Urol. 2023 Dec 8:101097JU0000000000003762. doi: 10.1097/JU.0000000000003762.
     PubMed    
     
     
     
159. SEFTEL AD
     Male and Female Sexual Function and Dysfunction; Andrology.
     J Urol. 2023;210:917-918.
     PubMed    
     
     
     
160. NIEDERBERGER C
     Male Infertility.
     J Urol. 2023;210:915-917.
     PubMed    
     
     
     November 2023
161. CHANG SS
     Urological Oncology: Bladder, Penis and Urethra Cancer, and Basic Principles of Oncology.
     J Urol. 2023 Nov 17:101097JU0000000000003784. doi: 10.1097/JU.0000000000003784.
     PubMed    
     
     
     
162. KOHN TP, Agrawal P, Ory J, Hare J, et al
     Rises in Hematocrit is Associated with an Increased Risk of Major Adverse Cardiac Events in Men Starting Testosterone Therapy - A Retrospective Cohort Claims Database Analysis.
     J Urol. 2023 Nov 10:101097JU0000000000003786. doi: 10.1097/JU.0000000000003786.
     PubMed     Abstract available
     
     
     
163. SESSINE MS, Radoiu CS, Qi J, Labardee C, et al
     Can MRI Help Inform Which Men with a History of Multifocal High Grade Prostatic Intraepithelial Neoplasia or Atypical Small Acinar Proliferation Remain at an Elevated Risk for Clinically Significant Prostate Cancer?
     J Urol. 2023 Nov 6:101097JU0000000000003775. doi: 10.1097/JU.0000000000003775.
     PubMed     Abstract available
     
     
     
164. MASTERSON TA, Molina M, Ledesma B, Zucker I, et al
     Platelet-rich Plasma for the Treatment of Erectile Dysfunction: A Prospective, Randomized, Double-blind, Placebo-controlled Clinical Trial. Reply.
     J Urol. 2023;210:734-735.
     PubMed    
     
     
     
165. GREEN B, Flores A, Warner J, Kohler T, et al
     Comparison of Collagenase Clostridium histolyticum to Surgery for the Management of Peyronie's Disease: A Randomized Trial.
     J Urol. 2023;210:791-802.
     PubMed     Abstract available
     
     
     
166. LEE EWC, Antonelli L, Issa A, Churchill J, et al
     Risk of Local Recurrence in Men With Penile Intraepithelial Neoplasia in the Surgical Margin After Penile-sparing Surgery.
     J Urol. 2023;210:778-781.
     PubMed     Abstract available
     
     
     October 2023
167. DANIELS JP, Mirocha J, Adjei M, Moreira D, et al
     Serum Testosterone and Dihydrotestosterone and Incidence and Progression of Lower Urinary Tract Symptoms: Results From the REDUCE Study.
     J Urol. 2023 Oct 24:101097JU0000000000003738. doi: 10.1097/JU.0000000000003738.
     PubMed     Abstract available
     
     
     
168. KANG C, Punjani N, Kashanian JA, Schlegel PN, et al
     Age, Sperm Retrieval, and Testicular Histology in Klinefelter Syndrome.
     J Urol. 2023 Oct 24:101097JU0000000000003737. doi: 10.1097/JU.0000000000003737.
     PubMed     Abstract available
     
     
     
169. KAPLAN SA
     Benign Prostatic Hyperplasia.
     J Urol. 2023 Oct 20:101097JU0000000000003731. doi: 10.1097/JU.0000000000003731.
     PubMed    
     
     
     
170. CHANG SS
     Urologic Oncology: Bladder, Penis, and Urethral Cancer, and Basic Principles of Oncology.
     J Urol. 2023 Oct 18:101097JU0000000000003735. doi: 10.1097/JU.0000000000003735.
     PubMed    
     
     
     
171. CLENNON EK, Duty B, Seideman C
     Overutilization of Transfer for Testicular Torsion: An Opportunity for Multilevel Policy Intervention.
     J Urol. 2023 Oct 13:101097JU0000000000003750. doi: 10.1097/JU.0000000000003750.
     PubMed    
     
     
     
172. AYANGBESAN A, Koch GE, Dagostino C, Proctor JM, et al
     Qualitative Analysis of Patient Experiences Reaching Urethroplasty for Recurrent Urethral Stricture Disease.
     J Urol. 2023 Oct 4:101097JU0000000000003722. doi: 10.1097/JU.0000000000003722.
     PubMed     Abstract available
     
     
     
173. PARK SH, Wilson SK, Wen L
     Subcoronal Incision for Inflatable Penile Prosthesis Does Not Risk Glans Necrosis.
     J Urol. 2023;210:678-687.
     PubMed     Abstract available
     
     
     September 2023
174. CHANG SS
     Urologic Oncology: Bladder, Penis, and Urethral Cancer, and Basic Principles of Oncology.
     J Urol. 2023 Sep 25:101097JU0000000000003719. doi: 10.1097/JU.0000000000003719.
     PubMed    
     
     
     
175. KAPLAN SA
     Benign Prostatic Hyperplasia.
     J Urol. 2023 Sep 25:101097JU0000000000003714. doi: 10.1097/JU.0000000000003714.
     PubMed    
     
     
     
176. STEPHENSON A, Bass EB, Bixler BR, Daneshmand S, et al
     Diagnosis and Treatment of Early-Stage Testicular Cancer: AUA Guideline Amendment 2023.
     J Urol. 2023 Sep 14:101097JU0000000000003694. doi: 10.1097/JU.0000000000003694.
     PubMed     Abstract available
     
     
     
177. SANDHU JS, Bixler BR, Dahm P, Goueli R, et al
     Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia (BPH): AUA Guideline Amendment 2023.
     J Urol. 2023 Sep 14:101097JU0000000000003698. doi: 10.1097/JU.0000000000003698.
     PubMed     Abstract available
     
     
     
178. KALYVIANAKIS D, Poulios E, Mykoniatis I, Pyrgidis N, et al
     Platelet-rich Plasma for the Treatment of Erectile Dysfunction: A Prospective, Randomized, Double-blind, Placebo-controlled Clinical Trial. Letter.
     J Urol. 2023 Sep 6:101097JU0000000000003684. doi: 10.1097/JU.0000000000003684.
     PubMed    
     
     
     
179. KAPLAN SA, Moss J, Freedman S, Coutinho K, et al
     The PINNACLE Study: A Double-blind, Randomized, Sham-controlled Study Evaluating the Optilume BPH Catheter System for the Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.
     J Urol. 2023;210:500-509.
     PubMed     Abstract available
     
     
     
180. NIEDERBERGER C
     Male Infertility.
     J Urol. 2023;210:553-555.
     PubMed    
     
     
     
181. SEFTEL AD
     Male and Female Sexual Function and Dysfunction; Andrology.
     J Urol. 2023;210:555-556.
     PubMed    
     
     
     
182. FRENDL DM, Chou WH, Chen YW, Chang DC, et al
     Early vs Delayed Transurethral Surgery in Acute Urinary Retention: Does Timing Make a Difference?
     J Urol. 2023;210:492-499.
     PubMed     Abstract available
     
     
     
183. RAGUE JT, Hirsch J, Meyer T, Streur C, et al
     "I Just Haven't Done Any of That": Applicability of the International Index of Erectile Function in Young Men With Spina Bifida.
     J Urol. 2023;210:538-547.
     PubMed     Abstract available
     
     
     August 2023
184. CHANG SS
     Urologic Oncology: Bladder, Penis, and Urethral Cancer, and Basic Principles of Oncology.
     J Urol. 2023 Aug 24:101097JU0000000000003660. doi: 10.1097/JU.0000000000003660.
     PubMed    
     
     
     
185. KAPLAN SA
     Benign Prostatic Hyperplasia.
     J Urol. 2023 Aug 23:101097JU0000000000003665. doi: 10.1097/JU.0000000000003665.
     PubMed    
     
     
     
186. STANIORSKI CJ, Myrga JM, Vasan RV, Klein RD, et al
     Surgical outcomes and prediction of complications following high complexity buried penis reconstruction.
     J Urol. 2023 Aug 16:101097JU0000000000003669. doi: 10.1097/JU.0000000000003669.
     PubMed     Abstract available
     
     
     
187. KAPLAN-MARANS E, Marans H
     Impact of Prostate Urethral Lift Device on Prostate Magnetic Resonance Image Quality. Letter.
     J Urol. 2023;210:251-252.
     PubMed    
     
     
     
188. SEFTEL AD
     Male and Female Sexual Function and Dysfunction; Andrology.
     J Urol. 2023;210:368-370.
     PubMed    
     
     
     
189. DI H, Wen Y
     Does Preoperative Testosterone Administration Decrease Complications in Distal Hypospadias Repair With Urethroplasty? Letter.
     J Urol. 2023 Aug 1:101097JU0000000000003636. doi: 10.1097/JU.0000000000003636.
     PubMed    
     
     
     
190. CHANG SS
     Urologic Oncology: Bladder, Penis, and Urethral Cancer, and Basic Principles of Oncology.
     J Urol. 2023 Aug 1:101097JU0000000000003630. doi: 10.1097/JU.0000000000003630.
     PubMed    
     
     
     July 2023
191. KAPLAN SA
     Benign Prostatic Hyperplasia.
     J Urol. 2023 Jul 25:101097JU0000000000003622. doi: 10.1097/JU.0000000000003622.
     PubMed    
     
     
     
192. GODLEWSKI K, Mittal S, Long C
     Does Preoperative Testosterone Administration Decrease Complications in Distal Hypospadias Repair With Urethroplasty? Reply.
     J Urol. 2023 Jul 14:101097JU0000000000003608. doi: 10.1097/JU.0000000000003608.
     PubMed    
     
     
     
193. MOSA H
     Does Preoperative Testosterone Administration Decrease Complications in Distal Hypospadias Repair With Urethroplasty? Letter.
     J Urol. 2023 Jul 6:101097JU0000000000003607. doi: 10.1097/JU.0000000000003607.
     PubMed    
     
     
     
194. SEFTEL AD
     Male and Female Sexual Function and Dysfunction; Andrology.
     J Urol. 2023;210:206-207.
     PubMed    
     
     
     
195. NIEDERBERGER C
     Male Infertility.
     J Urol. 2023;210:204-206.
     PubMed    
     
     
     June 2023
196. CHANG SS
     Urologic Oncology: Bladder, Penis, and Urethral Cancer, and Basic Principles of Oncology.
     J Urol. 2023 Jun 19:101097JU0000000000003577. doi: 10.1097/JU.0000000000003577.
     PubMed    
     
     
     
197. RICHIE JP
     Urologic Oncology: Testis Cancer and Advances in Oncologic Therapy.
     J Urol. 2023 Jun 19:101097JU0000000000003588. doi: 10.1097/JU.0000000000003588.
     PubMed    
     
     
     
198. KAPLAN SA
     Benign Prostatic Hyperplasia.
     J Urol. 2023 Jun 15:101097JU0000000000003580. doi: 10.1097/JU.0000000000003580.
     PubMed    
     
     
     
199. SEFTEL AD
     Male and Female Sexual Function and Dysfunction; Andrology.
     J Urol. 2023;209:1218-1221.
     PubMed    
     
     
     
200. NIEDERBERGER C
     Male Infertility.
     J Urol. 2023;209:1216-1218.
     PubMed    
     
     
     
201. STEPHENS-SHIELDS AJ, Lai HH, Landis JR, Kreder K, et al
     Clinically Important Differences for Pain and Urinary Symptoms in Urological Chronic Pelvic Pain Syndrome: A MAPP Network Study.
     J Urol. 2023;209:1132-1140.
     PubMed     Abstract available
     
     
     May 2023
202. RICHIE JP
     Urologic Oncology: Testis Cancer and Advances in Oncologic Therapy.
     J Urol. 2023 May 18:101097JU0000000000003542. doi: 10.1097/JU.0000000000003542.
     PubMed    
     
     
     
203. GODLEWSKI KF, Mittal S, Hyacinthe N, Fischer K, et al
     Does Preoperative Testosterone Administration Decrease Complications in Distal Hypospadias Repair with Urethroplasty?
     J Urol. 2023 May 17:101097JU0000000000003548. doi: 10.1097/JU.0000000000003548.
     PubMed     Abstract available
     
     
     
204. CHANG SS
     Urologic Oncology: Bladder, Penis, and Urethral Cancer, and Basic Principles of Oncology.
     J Urol. 2023 May 17:101097JU0000000000003540. doi: 10.1097/JU.0000000000003540.
     PubMed    
     
     
     
205. KAPLAN SA
     Benign Prostatic Hyperplasia.
     J Urol. 2023 May 9:101097JU0000000000003522. doi: 10.1097/JU.0000000000003522.
     PubMed    
     
     
     
206. RICHIE JP
     Urologic Oncology: Testis Cancer and Advances in Oncologic Therapy.
     J Urol. 2023 May 2:101097JU0000000000003474. doi: 10.1097/JU.0000000000003474.
     PubMed    
     
     
     
207. SEFTEL AD
     Male and Female Sexual Function and Dysfunction; Andrology.
     J Urol. 2023;209:1013-1014.
     PubMed    
     
     
     
208. RICHIE JP
     Urologic Oncology: Testis Cancer and Advances in Oncologic Therapy.
     J Urol. 2023;209:1028-1029.
     PubMed    
     
     
     
209. DAVARO F, Spiess PE
     Enlisting Urologists to Improve Palliative Care Services Integration in the Care of Advanced Penile Cancer.
     J Urol. 2023;209:824-826.
     PubMed    
     
     
     
210. CHANG SS
     Urologic Oncology: Bladder, Penis, and Urethral Cancer, and Basic Principles of Oncology.
     J Urol. 2023;209:1025-1026.
     PubMed    
     
     
     
211. RIVERO MJ, Ory J, Diaz P, Thirumavalavan N, et al
     Comparison of Hematocrit Change in Testosterone-Deficient Men Treated With Intranasal Testosterone Gel vs Intramuscular Testosterone Cypionate: A Randomized Clinical Trial.
     J Urol. 2023 May 1:101097JU0000000000003487. doi: 10.1097/JU.0000000000003487.
     PubMed     Abstract available
     
     
     April 2023
212. MASTERSON TA, Molina M, Ledesma B, Zucker I, et al
     Platelet-rich Plasma for the Treatment of Erectile Dysfunction: A Prospective, Randomized, Double-blind, Placebo-controlled Clinical Trial.
     J Urol. 2023 Apr 30:101097JU0000000000003481. doi: 10.1097/JU.0000000000003481.
     PubMed     Abstract available
     
     
     
213. BHOJANI N, Bidair M, Kramolowsky E, Desai M, et al
     Aquablation Therapy in Large Prostates (80-150 mL) for Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: Final WATER II 5-Year Clinical Trial Results.
     J Urol. 2023 Apr 28:101097JU0000000000003483. doi: 10.1097/JU.0000000000003483.
     PubMed     Abstract available
     
     
     
214. CHANG SS
     Urologic Oncology: Bladder, Penis, and Urethral Cancer, and Basic Principles of Oncology.
     J Urol. 2023 Apr 27:101097JU0000000000003465. doi: 10.1097/JU.0000000000003465.
     PubMed    
     
     
     
215. KAPLAN SA
     Benign Prostatic Hyperplasia.
     J Urol. 2023 Apr 20:101097JU0000000000003470. doi: 10.1097/JU.0000000000003470.
     PubMed    
     
     
     
216. TUTOLO M, Briganti A, Salonia A, Montorsi F, et al
     Role of Antimuscarinics Combined With Alpha-blockers in the Management of Urinary Storage Symptoms in Patients With Benign Prostatic Hyperplasia: An Updated Systematic Review and Meta-analysis.
     J Urol. 2023 Apr 13:101097JU0000000000003484. doi: 10.1097/JU.0000000000003484.
     PubMed    
     
     
     
217. LENFANT L, Pinar U, Roupret M, Mozer P, et al
     RE: RE: Role of Antimuscarinics Combined With Alpha-blockers in the Management of Urinary Storage Symptoms in Patients With Benign Prostatic Hyperplasia: An Updated Systematic Review and Meta-analysis.
     J Urol. 2023 Apr 13:101097JU0000000000003485. doi: 10.1097/JU.0000000000003485.
     PubMed    
     
     
     
218. SEFTEL AD
     Male and Female Sexual Function and Dysfunction; Andrology.
     J Urol. 2023;209:795-797.
     PubMed    
     
     
     
219. NIEDERBERGER C
     Male Infertility.
     J Urol. 2023;209:793-794.
     PubMed    
     
     
     March 2023
220. RICHIE JP
     Urologic Oncology: Testis Cancer and Advances in Oncologic Therapy.
     J Urol. 2023 Mar 23:101097JU0000000000003419. doi: 10.1097/JU.0000000000003419.
     PubMed    
     
     
     
221. KAPLAN SA
     Benign Prostatic Hyperplasia.
     J Urol. 2023 Mar 23:101097JU0000000000003415. doi: 10.1097/JU.0000000000003415.
     PubMed    
     
     
     
222. CHANG SS
     Urologic Oncology: Bladder, Penis, and Urethral Cancer, and Basic Principles of Oncology.
     J Urol. 2023 Mar 23:101097JU0000000000003411. doi: 10.1097/JU.0000000000003411.
     PubMed    
     
     

Thank you for your interest in scientific medicine.

AMEDEO Andrology is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum